Serelaxin (recombinant human relaxin-2) treatment affects the endogenous synthesis of long chain poly-unsaturated fatty acids and induces substantial alterations of lipidome and metabolome profiles in rat cardiac tissue.
We use our own and third-party cookies to be able to correctly offer you all the functionalities of the website, for analytical purposes and to show you personalized advertising according to a profile prepared from your browsing habits. You can accept all cookies by clicking "Accept cookies", obtain more information in our"
or configure them or reject their use by clicking on Configuration.".
Basic cookie information
Accept cookiesManage preferences
Technical and/or necessary cookiesAlways active
Technical cookies are those that facilitate user navigation and the use of the different options or services offered by the web such as identifying the session, allowing access to certain areas, facilitating orders, purchases, filling in forms, registration, security, facilitating functionalities. (videos, social networks…).
Analysis cookies are those used to carry out anonymous analysis of the behavior of web users and that allow user activity to be measured and navigation profiles to be created with the objective of improving websites.